ADC: Novák Š, Kolář M, Szabó A, Vernerová Z, Lacina L, Strnad H, Šáchová J, Hradilová M, Havránek J, Španko M, Čoma M, Urban L, Kaňuchová M, Melegová N, Gürlich R, Dvořák J, Smetana K Jr, Gál P, Szabo P. Desmoplastic Crosstalk in Pancreatic Ductal Adenocarcinoma Is Reflected by Different Responses of Panc-1, MIAPaCa-2, PaTu-8902, and CAPAN-2 Cell Lines to Cancer-associated/Normal Fibroblasts.

Cancer Genomics Proteomics. 2021 May-Jun;18(3):221-243. doi: 10.21873/cgp.20254. (IF=4,069, Q1) cit. 1x

ADC: Gál P, Vasilenko T, Kováč I, Čoma M, Jakubčo J, Jakubčová M, Peržeľová V, Urban L, Kolář M, Sabol F, Luczy J, Novotný M, Majerník J, Gabius HJ, Smetana KJ. Human galectin‑3: Molecular switch of gene expression in dermal fibroblasts in vitro and of skin collagen organization in open wounds and tensile strength in incisions in vivo. Mol Med Rep. 2021 Feb;23(2):99. doi: 10.3892/mmr.2020.11738. (IF= 2.952, Q3) cit. 2x

ADC: Coma M, Tothova E, Guman T, Hajikova M, Giertlova M, Sarissky M.Altered expression pattern of SLAM family receptors on pathological B cells of patients with chronic lymphocytic leukemia. Leuk Lymphoma. 2017 Jul;58(7):1726-1729. doi:10.1080/10428194.2016.1251593. (IF= 2.459, Q2) cit.3x

ADC: Fáber L, Kováč I, Mitrengová P, Novotný M, Varinská L, Vasilenko T, Kello M, Čoma M, Kuruc T, Petrová K, Miláčková I, Kuczmannová A, Peržeľová V, Mižáková Š, Dosedla E, Sabol F, Luczy J, Nagy M, Majerník J, Koščo M, Mučaji P, Gál P.. Genistein Improves Skin Flap Viability in Rats: A Preliminary In Vivo and In Vitro Investigation. Molecules. 2018 Jul 4;23(7):1637. doi: 10.3390/molecules23071637 (IF= 3,060, Q2) cit.5x

ADC: Čoma M, Fröhlichová L, Urban L, Zajíček R, Urban T, Szabo P, Novák Š, Fetissov V, Dvořánková B, Smetana K Jr, Gál P. Molecular Changes Underlying Hypertrophic Scarring Following Burns Involve Specific Deregulations at All Wound Healing Stages (Inflammation, Proliferation and Maturation). Int J Mol Sci. 2021 Jan 18;22(2):897. doi: 10.3390/ijms22020897 (IF= 5.924, Q1) cit.6x

EU founds: OPENMED Code ITMS2014+:313011V455. 2021-present time. Project team member: RNDr. Matus Coma, PhD.

APVV-16-0446. Cell interactions in tumor microenvironment and their pharmacological modulations.2017-2021. Project team member: RNDr. Matus Coma, PhD.

APVV-20-0017. The development of active wound dressings based on antibacterial hydrogel contains a plant extract that stimulates healing. 2021-present time. Project team member: RNDr. Matus Coma, PhD.

VEGA 1/0539/21; Fibroblasts and tumor microenvironment: cell interactions and their pharmacological modulation. 2021-2024. Project team member: RNDr. Matus Coma, PhD.

VEGA 1/0905/12. Expression of SLAM family receptors in human hematological malignancies. 2013-2017. Project team member: RNDr. Matus Coma, PhD.